Carl June, MD

A pioneer in CAR T-cell therapy, Dr. June is the Richard W. Vague Professor in Immunotherapy at the University of Pennsylvania’s Perelman School of Medicine and the director of the Center for Cellular Immunotherapies. He is also the director of the Parker Institute for Cancer Immunotherapy. His groundbreaking work in developing chimeric antigen receptor (CAR) T-cell immunotherapy earned him the 2024 Breakthrough Prize in Life Sciences.

Dr. June has published over 450 manuscripts and has been recognized with numerous awards and honors, including election to the Institute of Medicine in 2012 and the American Academy of Arts and Sciences in 2014. His contributions to the field of immunotherapy have sparked a new path in cancer care and continue to inspire the medical community.